Find out more about who we are, what we do and the people behind Epitopea.
Find out what makes us unique and the work we do with our revolutionary CryptoMapTM platform.
All the latest company news, press releases and updates from Epitopea.
Contact

News & Events

Revealing the true targets for next generation immunotherapies.
Learn More

Epitopea Announces License and Research Collaboration Agreement with MSD to Identify CryptigenTM Tumor-Specific Antigens

Date: February 19, 2025 |
Montreal, Quebec and Cambridge, UK February 19, 2025: Epitopea, a transatlantic cancer immunotherapeutics company developing accessible, off-the-shelf RNA-based immunotherapies, announces […]
Read More

Epitopea Appoints Klaus Edvardsen M.D., Ph.D. as Chief Medical Officer 

Date: February 7, 2025 |
CAMBRIDGE, UK and MONTREAL, CANADA, 7 February 2025 — Epitopea, a transatlantic cancer immunotherapeutics company developing accessible off-the-shelf RNA-based immunotherapies, […]
Read More

Epitopea and Genevant Sciences Announce Collaboration Agreement

Date: December 19, 2024 |
CAMBRIDGE, UK, MONTREAL, CANADA, VANCOUVER, CANADA, and BASEL, SWITZERLAND — December 19, 2024 (GLOBE NEWSWIRE) — Epitopea, a transatlantic cancer […]
Read More

Epitopea featured in Cambridge Independent

Date: November 4, 2024 |
Epitopea’s $31m pre-Series A is boost for RNA immunotherapies clinical trials Epitopea’s transatlantic business model has been boosted by a […]
Read More

Epitopea Closes USD $31 million Pre-Series A Financing

Date: October 24, 2024 |
Proceeds support strategic development and clinical entry of lead Cryptigen immunotherapeutics CAMBRIDGE, UK and MONTREAL, CANADA, 24 October 2024 - […]
Read More

CQDM and Epitopea Fund the Development and Validation of CryptoMapTM a Platform Enabling the Development of RNA-based Immunotherapies

Date: September 26, 2024 |
Montreal, Quebec, 26 September 2024 – Epitopea, a transatlantic cancer immunotherapy company, and CQDM are proud to announce the launch […]
Read More
1 2

Upcoming Events

Connect with Epitopea at these upcoming events

News Categories

Revealing Novel Targets For Next Generation Immunotherapies
© 2022 – 2025 Epitopea Ltd | All Rights Reserved
Created by FDM Digital